Table 3 – Acquisition Program Baselines (APBs)

Table 3 is located in Enclosure 1 Section 4 APBs and Baseline Breaches.

 

Table 3. APBs
Original Baseline Description, Original APB, or Original Estimate

For all programs:

  • The first APB is approved by the MDA prior to a program entering Engineering and Manufacturing Development, or at program initiation, whichever occurs later.
  • Serves as the current baseline description until a revised APB is approved.
  • Incorporates the KPPs from the CDD or CPD (if program initiation is at Milestone The point at which a recommendation is made and approval sought regarding starting or continuing an acquisition program, i.e., proceeding to the next phase. Milestones established by DoDI 5000.02 are: Milestone A that approves entry into the Technology Maturation and Risk Reduction phase; Milestone B that approves entry into the Engineering and Manufacturing Development phase; and Milestone C that approves entry into the Production and Deployment phase. C).

For MDAPs:

  • The cost/unit cost estimate parameters may be revised under 10 U.S.C. 2435 (Reference (h)) only if a breach occurs that exceeds the critical cost growth threshold for the program under 10 U.S.C. 2433 (Reference (h)).

For MAIS Programs:

  • The Original Estimate is the initial schedule, performance, cost baseline submitted to Congress in a MAIS Annual Report (MAR), and can only be revised under 10 U.S.C. 2445c (Reference (h)) following a Critical Change Report to Congress.
  • The Original Estimate is created from the objective schedule and cost values, and the performance threshold values in the first APB approved by the MDA.
  • The statutory term, “development cost,” will be treated the same as “total acquisition cost.”
Current Baseline Description or Current APB
  • May be revised only:
    • At milestone and FRP and FD decisions;
    • As a result of a major program restructure that is fully funded and approved by the MDA;
    • As a result of a program deviation (breach); or
    • At the MDA’s discretion if fact of life program changes are so significant that managing to the existing baseline is not practical. 
  • Circumstances authorizing changes are limited; revisions to the current baseline estimate/APB are not automatically authorized for program changes to cost, schedule, or performance parameters.
  • Revisions to the current APB will not be authorized unless there is a significant change in program parameters.
  • A revision to the current APB will not be authorized if proposed merely to avoid a reportable breach.
  • The MDA determines whether to revise the APB.
Deviations
  • The Program Manager will immediately notify the MDA when the Program Manager becomes aware of an impending deviation from any parameter (cost, schedule, performance, etc.)
  • Within 30 business days of occurrence of the deviation, the Program Manager will submit a Program Deviation Report that informs the MDA of the reason for the deviation and planned actions.
  • Within 90 business days of occurrence of the deviation:
    • The Program Manager will bring the program back within APB parameters; or
    • The Program Manager will submit information to the OIPT to inform a recommendation to the MDA on whether it is appropriate to approve a revision to an APB. 
  • The MDA will decide, after considering the recommendation resulting from the OIPT or equivalent Component-level review, whether it is appropriate to approve a revision to an APB.
Subprograms (10 U.S.C. 2430a (Reference (h)) When an MDAP requires the delivery of two or more categories of end items that differ significantly in form and function, or the delivery of satellites in two or more increments or blocks, subprograms may be established for baselining and reporting purposes. Once one subprogram is designated, all remaining elements (increments or components) of the program will also be appropriately organized into one or more other subprograms.
Share This